Published in EMBO J on September 01, 1994
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J (2003) 2.17
HSF4, a new member of the human heat shock factor family which lacks properties of a transcriptional activator. Mol Cell Biol (1997) 1.96
RelB regulation of chemokine expression modulates local inflammation. Am J Pathol (1997) 1.50
Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Nat Immunol (2012) 1.48
NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J Exp Med (2003) 1.33
p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med (1997) 1.32
RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts. Mol Cell Biol (1999) 1.28
Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci U S A (1995) 1.22
Stabilization of RelB requires multidomain interactions with p100/p52. J Biol Chem (2008) 1.21
Celebrating 25 years of NF-κB research. Immunol Rev (2012) 1.19
A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB. J Exp Med (1996) 1.11
Activation of NF-kappaB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter. Mol Cell Biol (1996) 1.08
Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01
Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells. J Virol (1999) 0.99
Regulation of RelB expression during the initiation of dendritic cell differentiation. Mol Cell Biol (2005) 0.93
RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci U S A (2000) 0.92
Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production. PLoS One (2010) 0.90
Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology (1999) 0.90
Characterization of elements determining the dimerization properties of RelB and p50. Mol Cell Biol (1995) 0.90
Glutamate-induced NFkappaB activation in the retina. Invest Ophthalmol Vis Sci (2008) 0.88
Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression. Respir Res (2015) 0.85
RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke. Am J Respir Cell Mol Biol (2008) 0.85
The nfkb1 promoter is controlled by proteins of the Ets family. Mol Biol Cell (1997) 0.84
Differential utilization of NF-kappaB RELA and RELB in response to extracellular versus intracellular polyIC stimulation in HT1080 cells. BMC Immunol (2011) 0.79
Constitutive nuclear NF kappa B/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem J (1995) 0.77
Evidence for active antigen presentation by monocyte/macrophages in response to stimulation with particles: the expression of NFκB transcription factors and costimulatory molecules. Inflammopharmacology (2013) 0.77
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (1988) 16.40
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell (1988) 11.62
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell (1989) 11.19
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell (1990) 9.37
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell (1990) 9.24
NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science (1993) 9.03
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42
The origin of pattern and polarity in the Drosophila embryo. Cell (1992) 7.40
Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature (1993) 6.75
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell (1991) 6.49
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J (1991) 6.08
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev (1992) 5.67
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev (1993) 4.93
Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (1990) 4.61
CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev (1989) 4.47
Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell (1990) 4.37
The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev (1993) 4.23
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol (1992) 4.03
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element. Proc Natl Acad Sci U S A (1988) 3.97
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell (1991) 3.84
NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci (1992) 3.81
Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1991) 3.80
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63
NF-kappa B, KBF1, dorsal, and related matters. Cell (1990) 3.51
DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell (1990) 3.44
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell (1993) 3.35
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO J (1993) 3.30
NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J (1991) 3.28
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell (1992) 3.25
Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature (1987) 3.19
In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J (1993) 3.11
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J (1993) 2.71
NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science (1992) 2.69
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature (1992) 2.50
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol (1990) 2.47
Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28
Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27
Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins. Cell (1992) 2.21
Oncogenic transformation by vrel requires an amino-terminal activation domain. Mol Cell Biol (1990) 2.15
cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the I kappa B gene family of vertebrates. Cell (1992) 2.12
The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol (1993) 1.93
pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell (1993) 1.81
Dissociation of the dorsal-cactus complex and phosphorylation of the dorsal protein correlate with the nuclear localization of dorsal. J Cell Biol (1993) 1.70
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J (1993) 1.61
Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development (1993) 1.48
Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol Cell Biol (1993) 1.46
Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei. Eur J Biochem (1984) 1.46
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35
Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function. EMBO J (1988) 1.33
A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol (1991) 1.29
Dorsal, a Drosophila Rel-like protein, is phosphorylated upon activation of the transmembrane protein Toll. Mol Cell Biol (1994) 1.28
A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol (1993) 1.26
Purification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol Cell Biol (1994) 1.04
Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev (1993) 1.02
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res (1991) 1.01
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J (1994) 0.95
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (1987) 4.11
NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28
A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet (1996) 2.16
Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science (1997) 1.93
Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem (2001) 1.92
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56
Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54
[Colonic stenting: an opportunity with a risk : A critical evaluation]. Chirurg (2015) 1.38
Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci U S A (2000) 1.36
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut (2005) 1.34
Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (MuRRS). Nucleic Acids Res (1985) 1.33
Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J Biol Chem (1999) 1.27
Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood (1998) 1.25
Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci U S A (2001) 1.24
Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J (2001) 1.23
Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol (1993) 1.19
The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res (1994) 1.13
Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1. J Biol Chem (1995) 1.10
Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev (1995) 1.06
Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res (2001) 1.05
Evidence for mobility of a new family of mouse middle repetitive DNA elements (LTR-IS). Nucleic Acids Res (1984) 1.03
Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol (2004) 1.02
Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene (1995) 1.02
CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01
Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res (1991) 1.01
Mitochondrial differentiation in a polymorphic land snail: evidence for Pleistocene survival within the boundaries of permafrost. J Evol Biol (2003) 1.01
Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther (2006) 1.00
Model for estimating enteric methane emissions from United States dairy and feedlot cattle. J Anim Sci (2008) 1.00
Failures and complications in intramedullary nailing of children's forearm fractures. J Child Orthop (2010) 0.99
The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98
Treatment of severely displaced proximal humeral fractures in children with retrograde elastic stable intramedullary nailing. Injury (2008) 0.98
Evidence that a major class of mouse endogenous long terminal repeats (LTRs) resulted from recombination between exogenous retroviral LTRs and similar LTR-like elements (LTR-IS). Proc Natl Acad Sci U S A (1984) 0.97
NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev (2000) 0.96
The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells. Eur J Immunol (2000) 0.96
Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther (2003) 0.96
[Treatment of congenital clubfoot with the Ponseti method]. Z Orthop Ihre Grenzgeb (2006) 0.95
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J (1994) 0.95
CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93
Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol (2008) 0.92
Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression. Am J Med Genet (1999) 0.92
Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. Histol Histopathol (2005) 0.91
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J Biol Chem (1993) 0.90
Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther (2006) 0.89
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res (1994) 0.89
Induction of nuclear factor-kappa B during primary B cell differentiation. J Immunol (1998) 0.87
Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice. Nucleic Acids Res (1992) 0.86
Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene (2012) 0.85
Isolation and characterization of microsatellite loci in the yellow perch (Perca flavescens), and cross- species amplification within the family Percidae. Mol Ecol (2000) 0.85
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Gene Ther (2009) 0.84
[Treatment of vertical talus with the Dobbs method]. Z Orthop Unfall (2011) 0.83
Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood (2001) 0.83
Arthroscopic reduction of the dislocated hip in infants. J Bone Joint Surg Br (2012) 0.83
Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res (1991) 0.82
[Wound secretions in standard orthopedic surgery interventions using a new kind of closed vacuum drainage. A report of experiences]. Unfallchirurg (1991) 0.82
The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene (2010) 0.81
The influence of intermittent external dynamic pressure and tension forces on the healing of an epiphyseal fracture. Arch Orthop Trauma Surg (2001) 0.80
No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats. Eur J Pharmacol (1998) 0.80
Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy. Cancer Gene Ther (2012) 0.80
Glutamate-dependent activation of NF-kappaB during mouse cerebellum development. J Neurosci (1997) 0.80
Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein. Gene Ther (2003) 0.80
[Mid-term results of idiopathic clubfeet treated with the Ponseti method]. Z Orthop Unfall (2012) 0.79
Identification of target genes of the lymphoid-specific transcription factor Oct2. Immunobiology (1997) 0.79
[Diagnosis and therapy of coxitis fugax with special reference to the value of ultrasonographY-assisted diagnosis and hip joint puncture]. Z Orthop Ihre Grenzgeb (1993) 0.79
Novel polymer-bound chiral selenium electrophiles. Org Lett (2001) 0.79
Assessment of the treatment costs of extracorporeal shock wave therapy versus surgical treatment for shoulder diseases. Int J Technol Assess Health Care (2001) 0.79
Demethylation and the establishment of kappa allelic exclusion. Cold Spring Harb Symp Quant Biol (1999) 0.79
RelB is a key player for both kappa B-dependent transcription and demethylation in B cells. Immunobiology (1997) 0.79
Genetic signatures in an invasive parasite of Anguilla anguilla correlate with differential stock management. J Fish Biol (2010) 0.78
[Predicting the outcome of diskectomy.]. Schmerz (1991) 0.78
In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Ther (1999) 0.78
Molecular genetics of the germinal center reaction. J Cell Physiol (1998) 0.78
Analysis of promoter activity by polymerase chain reaction amplification of reporter gene mRNA. Anal Biochem (1996) 0.77
Isolation and characterization of 12 dinucleotide microsatellites in the European eel, Anguilla anguilla L., and tests of amplification in other species of eels. Mol Ecol Resour (2008) 0.77
The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation. J Biol Chem (1998) 0.77
ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. Leukemia (2008) 0.77
Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somat Cell Mol Genet (1996) 0.76
[Elastic stable intramedullary nailing as alternative therapy for the management of paediatric humeral shaft fractures]. Z Orthop Unfall (2009) 0.76
[Is conservative treatment of partial or complete anterior cruciate ligament rupture still justified? An analysis of the recent literature and a recommendation for arriving at a decision]. Z Orthop Ihre Grenzgeb (1992) 0.76
Controversies in childhood osteosarcoma. Minerva Pediatr (2013) 0.76
[Minimally invasive treatment of congenital foot deformities in infants: new findings and midterm-results]. Orthopade (2013) 0.76
Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression. J Cancer Res Clin Oncol (2005) 0.76
[Coxitis fugax--the beginning of Perthes' disease?]. Z Orthop Ihre Grenzgeb (2006) 0.75
False-positive sonographic hip examinations in newborns with congenital varus deformity of the proximal femur. Arch Orthop Trauma Surg (1995) 0.75
[The effect of asbestos cement, UICC asbestos samples and quartz on the peritoneum of the mouse]. Pathol Microbiol (Basel) (1975) 0.75
Comprehensive comparison of various techniques for the analysis of elemental distributions in thin films. Microsc Microanal (2011) 0.75
[Contribution to the study of medullary lines in reptiles. Erythrocyte and plasmocyte lines]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.75
[An update on thrombosis prophylaxis in orthopaedic and accident surgery]. Orthopade (2004) 0.75
[Comparison of the diagnostic value of X-ray versus MRI in paediatric spine injuries]. Z Orthop Unfall (2011) 0.75